Related Experiment Video
Updated: Apr 21, 2026

A Fluorescence-based Assay for Characterization and Quantification of Lipid Droplet Formation in Human Intestinal Organoids
Published on: October 13, 2019
LDIflare small fiber function in normal glucose tolerant subjects with and without hypertriglyceridemia
Prashanth Rj Vas1, Sanjeev Sharma1, Gerry Rayman1
1Ipswich Diabetes Centre, Heath Road, Ipswich, Suffolk, IP4 5PD, United Kingdom.
Introduction:
We explored determinants of small fiber function (SFF) in normoglycemic individuals to determine influence of metabolic parameters, including triglyceride (TG) levels.
Methods:
Dorsal foot SFF was assessed by the LDIflare method in 79 individuals without clinical neuropathy, including 43 controls (HC, <1.7 mmol/L), 17 with mild hypertriglyceridemia (MiTG, 1.7-2.25), and 19 with significant hypertriglyceridemia (HiTG, >2.25 mmol/L).
Results:
LDIflare was significantly smaller in HiTG compared with HC (4.4 ± 1.4 vs. 9.3 ± 2.9 cm(2) ; P < 0.0001) and compared with the MiTG (4.4 ± 1.4 vs. 7.0 ± 2.1; P < 0.0001). Over all, an inverse correlation existed between LDIflare and age (-0.42; P < 0.0001), weight (r = -0.37; P = 0.004), body mass index (BMI) (-0.51; P < 0.0001), Log10 triglycerides (r = -0.66; P < 0.0001), total cholesterol (r = -0.26; P = 0.02), and TC/HDL ratio (r = -0.40; P = 0.002). In multivariate regression analysis, Log10 triglycerides (P < 0.0001) and age (P = 0.003) were the only independent predictors.
Conclusions:
There is an inverse correlation between small fiber function and triglycerides in normoglycemic individuals and abnormal SFF in normoglycemic hypertriglyceridemia. Larger prospective studies are required to confirm these findings and to determine whether reduced SFF heralds later clinical neuropathy.
Related Concept Videos
Type I Diabetes II: Pathophysiology
Type II Diabetes II: Pathophysiology
Dipeptidyl Peptidase 4 Inhibitors
Oral Hypoglycemic Agents: Glinides
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...

